WORLD HEALTH ORGANIZATION

The global personalized medicine biomarkers market is projected to grow from USD 21.85 billion in 2024 to USD 78.27 billion by 2034, at a CAGR of 13.6%. Biomarkers aid in early disease detection, prognosis, and treatment selection, driving market growth. Key drivers include advancements in genomics, growing prevalence of diseases like cancer, and partnerships between pharmaceutical and diagnostic firms. North America leads the market, while Asia Pacific is expected to grow fastest due to expanding healthcare infrastructure and rising demand for precision medicine.

Mayo Clinic's phase 2 study shows promising results with short-course hypofractionated proton beam therapy for older patients with glioblastoma, improving median overall survival to 13.1 months and quality of life.

References on tuberculosis research, including WHO reports, new TB vaccines, drug resistance, and treatment regimens.

King Charles reduces red meat in his diet to aid cancer battle. Research indicates plant-based foods improve cancer prognosis, while red meat may increase cancer risk. A balanced diet rich in fruits, vegetables, and whole grains is recommended for cancer prevention and survivorship.

China's Sinopharm approved clinical trials for a domestically developed mpox vaccine, jointly created by the Beijing Institute of Biological Products and the National Institute for Viral Disease Control and Prevention. The vaccine has shown safety and efficacy in preclinical research, with complete proprietary intellectual property rights. Another Sinopharm subsidiary, the Shanghai Institute of Biological Products, also received approval for clinical trials in September. The Institute of Microbiology under the Chinese Academy of Sciences is researching an mRNA-based mpox vaccine with positive results in mice studies.

WHO's first drowning prevention report shows a 38% global drop in drowning deaths since 2000, but 300,000 still drown annually. Half of deaths occur under 29, a quarter under 5. Progress varies; 90% of deaths in low- and middle-income countries. WHO recommends community-based actions like barriers, swimming lessons, and rescue training. Only 33% of countries train bystanders, and 22% include water safety in schools. 65% collect drowning data, but 86% lack pool fencing laws. The report emphasizes a coordinated, whole-society response for prevention.

Robert F. Kennedy Jr.'s attorney, Aaron Siri, lobbied FDA to revoke polio vaccine approval. Siri, a vaccine opponent, filed petitions to pause other vaccines. Kennedy did not respond to questions on his stance or potential HHS intervention.

Trump praised polio vaccine as 'greatest thing,' while lawyer Aaron Siri petitioned FDA to revoke U.S. vaccine approval. Siri, affiliated with Trump's HHS pick Robert F. Kennedy Jr., seeks double-blind trial for vaccine safety. Polio vaccination is a global public health achievement, though Siri's petition questions its safety without placebo-controlled trials. The inactivated polio vaccine used in the U.S. is safer than the oral version, protecting against severe outcomes but not transmission.

Precision medicine in mental health, driven by genetic solutions, promises personalized treatments, addressing efficacy and side effects. Adaptive trial designs accelerate drug development, while ethical concerns and infrastructure changes are challenges. Financial investments and community advocacy shift focus to integrative care models.

President-elect Trump praised the polio vaccine as 'the greatest thing,' while lawyer Aaron Siri petitioned the FDA to revoke approval of the U.S. polio vaccine. Siri, affiliated with Trump's HHS pick Robert F. Kennedy Jr., filed the petition in 2022, questioning vaccine safety. The FDA is reviewing the petition, while Kennedy has stated he supports informed vaccine choice. Trump also expressed openness to removing certain vaccines if deemed dangerous. Polio vaccination is hailed as a global public health achievement, with the inactivated polio vaccine used in the U.S. considered safe and effective.